Weight Loss
Daily sublingual tablet
Dual agonist, no injection
Dual GIP and GLP-1 action in a daily sublingual format for needle-free patients who want the dual-agonist mechanism.
Prescription treatment. Prescribed only when clinically appropriate, after review by a licensed provider.
What to expect
Dual receptor mechanism without injection
Daily routine rather than weekly scheduling
Discreet format
Straightforward to discontinue
How it works
Delivers tirzepatide through sublingual absorption, targeting both incretin receptors. As with oral semaglutide, blood levels vary more than with injection.
Individual results vary.
Dosing
Once daily on an empty stomach, held under the tongue as directed. Your provider sets the starting strength and adjusts from there.
Safety information
Possible side effects
Not suitable for
Prescription treatment. Prescribed only when clinically appropriate, after review by a licensed provider. This is not a complete list of risks. Your provider will review your full medical history before prescribing.
Questions
Purely format preference. If needles are a barrier that would stop you starting or continuing, the oral route is the better clinical choice for you.
Ready when you are
A licensed provider reviews your intake and prescribes sublingual tirzepatide only when clinically appropriate. Individual results vary.
Start your online visitPrescription treatment. Prescribed only when clinically appropriate, after review by a licensed provider.
